Swiss National Bank’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Buy |
106,400
+11,700
| +12% | +$624K | ﹤0.01% | 1218 |
|
|
2025
Q1 | $3.83M | Sell |
94,700
-900
| -0.9% | -$36.4K | ﹤0.01% | 1416 |
|
|
2024
Q4 | $2.66M | Buy |
95,600
+1,100
| +1% | +$30.6K | ﹤0.01% | 1693 |
|
|
2024
Q3 | $2.71M | Sell |
94,500
-7,500
| -7% | -$215K | ﹤0.01% | 1684 |
|
|
2024
Q2 | $2.39M | Sell |
102,000
-3,000
| -3% | -$70.4K | ﹤0.01% | 1718 |
|
|
2024
Q1 | $2.65M | Buy |
105,000
+17,400
| +20% | +$440K | ﹤0.01% | 1685 |
|
|
2023
Q4 | $2.05M | Sell |
87,600
-9,700
| -10% | -$226K | ﹤0.01% | 1816 |
|
|
2023
Q3 | $4.92M | Buy |
97,300
+1,000
| +1% | +$50.6K | ﹤0.01% | 1290 |
|
|
2023
Q2 | $4.5M | Buy |
96,300
+30,700
| +47% | +$1.43M | ﹤0.01% | 1373 |
|
|
2023
Q1 | $2.51M | Sell |
65,600
-5,400
| -8% | -$207K | ﹤0.01% | 1696 |
|
|
2022
Q4 | $3.89M | Buy |
71,000
+1,800
| +3% | +$98.6K | ﹤0.01% | 1465 |
|
|
2022
Q3 | $2.36M | Buy |
69,200
+19,800
| +40% | +$674K | ﹤0.01% | 1753 |
|
|
2022
Q2 | $467K | Buy |
49,400
+12,300
| +33% | +$116K | ﹤0.01% | 2624 |
|
|
2022
Q1 | $526K | Buy |
37,100
+2,700
| +8% | +$38.3K | ﹤0.01% | 2596 |
|
|
2021
Q4 | $728K | Hold |
34,400
| – | – | ﹤0.01% | 2575 |
|
|
2021
Q3 | $769K | Hold |
34,400
| – | – | ﹤0.01% | 2499 |
|
|
2021
Q2 | $853K | Sell |
34,400
-900
| -3% | -$22.3K | ﹤0.01% | 2534 |
|
|
2021
Q1 | $1.02M | Hold |
35,300
| – | – | ﹤0.01% | 2338 |
|
|
2020
Q4 | $911K | Buy |
35,300
+700
| +2% | +$18.1K | ﹤0.01% | 2338 |
|
|
2020
Q3 | $1.07M | Buy |
34,600
+12,200
| +54% | +$376K | ﹤0.01% | 2062 |
|
|
2020
Q2 | $558K | Buy |
+22,400
| New | +$558K | ﹤0.01% | 2357 |
|